Research

Hormonal

Lorcaserin, a selective 5-HT2C receptor agonist, produces significant, dose-dependent weight loss in obese adults without the need for concurrent diet or exercise modifications.

Lorcaserin is a prescription medication that activates specific brain receptors to reduce appetite. In this 12-week study, obese adults lost an average of 3.6 kg on the highest dose without changing their diet or exercise habits. It is not a standalone solution but a tool to help regulate hunger signals.

GoodSupportsHIGH confidence
Lorcaserin was associated with progressive weight loss of 1.8 kg, 2.6 kg, and 3.6 kg at 10 mg q.d., 15 mg q.d., and 10 mg b.i.d., respectively, compared to placebo weight loss of 0.3 kg (P < 0.001 for each group)... The weight loss in lorcaserin-treated patients was achieved without the prescription of concurrent calorie restriction or increased physical activity.
Steven R. Smith et al. · Obesity · 2008

Why this rating

Randomized, double-blind, placebo-controlled trial with 469 participants, though limited to 12 weeks.

Source

Lorcaserin (APD356), a Selective 5‐HT<sub>2C</sub>Agonist, Reduces Body Weight in Obese Men and Women

Steven R. Smith et al. · Obesity · 2008

DOI 10.1038/oby.2008.537

rct · n=469Cited 191×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →